Personalised blueprint of chronic inflammation in health-to-disease transition

Last updated: 16.7.2025
Grant

The 'Personalised blueprint of chronic inflammation in health-to-disease transition' program, under Horizon Europe's Health cluster, aims to develop personalised approaches for disease prevention by understanding the role of chronic inflammation. This initiative seeks to provide optimal counselling and effective tools for citizens and healthcare professionals, fostering healthier lifestyles and reducing the burden of chronic diseases through innovative research and digital solutions.

Who is Funded

This section provides an overview of who is eligible for funding under the 'Personalised blueprint of chronic inflammation in health-to-disease transition' program, outlining the types of entities that can apply, the geographical areas covered, and the overarching objectives the program aims to achieve.

What is Funded

This section details the types of projects, thematic areas, and activities eligible for funding, including a clarification of covered costs and the typical developmental stage of supported initiatives.

Type and Scope of Funding

This section outlines the financial aspects of the funding program, including the nature of the financial support, the available funding amounts, and the expected duration of projects.

Conditions and Requirements

This section outlines the essential conditions, requirements, and regulations that applicants and beneficiaries must adhere to throughout the application and project implementation phases.

Application Procedure

This section guides applicants through the procedural aspects of securing funding, from application submission to the evaluation and decision-making processes.

This section outlines the fundamental legal and official documents that establish and govern the 'Personalised blueprint of chronic inflammation in health-to-disease transition' funding program, ensuring transparency and legal compliance.

Similar Programs

#Personalised prevention#chronic inflammation#health-to-disease transition#Horizon Europe#health research#disease prevention#biomarkers#health determinants#personalised interventions#innate immunity#systems analysis#data-driven health#medical technology#EU funding#healthcare innovation#clinical studies#digital health

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

7,000,000 EUR

Allocated Budget

Allocated Budget:

50,000,000 EUR

Deadline

Deadline:

21.04.2022

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

EU Member States, Associated Countries, and the United States of America.

Sectors

Sectors:

Healthcare, Medical Technology, Research and Development, Information and Communication Technology, Software Development

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Basic Research, Applied Research, Experimental Development, Pilot Testing

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

0 x 0
XS